About Maxtreme Pharma Limited
Data last updated:
Maxtreme Pharma Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 03 September 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51501MH2015PLC268068.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Gaurav Chawla and Sanjeev Kumar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at B 1908 Mit Niketan 90 Feet Road Thakur Complex Kandivali East, Mumbai, Maharashtra, India – 400101.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website maxtremepharma.com.
Company details
Contact details
Maxtreme Pharma Limited's registered office is in Mumbai, Maharashtra. Its website is maxtremepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressB 1908 Mit Niketan 90 Feet Road Thakur Complex Kandivali East, Mumbai, Maharashtra, India – 400101
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Maxtreme Pharma Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Maxtreme Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Maxtreme Pharma Limited
FY 2024 filings availableFinancial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Maxtreme Pharma Limited, buy the company report.
Board of directors of Maxtreme Pharma Limited
Maxtreme Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gaurav Chawla | Director | 03 Sep 2015 | 11 Years 1 Months | Current |
| Sanjeev Kumar Also directs: Cloudncloud Tech Limited | Director | 03 Sep 2015 | 11 Years 1 Months | Current |
| Gulzar Singh Also directs: Cloudncloud Tech Limited, Maxgars Nutraceuticals Limited, Amrit Remedies Private Limited and 4 more | Director | 03 Sep 2015 | 11 Years 1 Months | Current |
Auditor
Maxtreme Pharma Limited is audited by SANADHYA MANDOT & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANADHYA MANDOT & ASSOCIATES | FY 2021 | 017991C |
Shareholding
The shareholding of Maxtreme Pharma Limited is on record for 2 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Maxtreme Pharma Limited, buy the company report.
Legal cases
No court or tribunal cases involving Maxtreme Pharma Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Maxtreme Pharma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Maxtreme Pharma Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Maxtreme Pharma Limited has 3 board changes on record since 2015: 3 appointments. The latest: Gaurav Chawla was appointed as Director on 03 Sep 2015.
Frequently asked questions
Maxtreme Pharma is an active public limited company based in Mumbai, Maharashtra, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 03 September 2015 (11+ years old) and is registered under CIN U51501MH2015PLC268068.
Maxtreme Pharma has 3 current directors:
- Gaurav Chawla - Director
- Sanjeev Kumar - Director
- Gulzar Singh - Director
The latest financial statements of Maxtreme Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2016 are in the company report.
The CIN (Corporate Identification Number) of Maxtreme Pharma is U51501MH2015PLC268068. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maxtreme Pharma was incorporated on 03 September 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
Gaurav Chawla was appointed as Director on 03 Sep 2015. Gulzar Singh was appointed as Director on 03 Sep 2015. Sanjeev Kumar was appointed as Director on 03 Sep 2015.
Maxtreme Pharma can be reached through the website maxtremepharma.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Maxtreme Pharma is at B 1908 Mit Niketan 90 Feet Road Thakur Complex Kandivali East, Mumbai, Maharashtra, India – 400101.
Maxtreme Pharma operates in the chemicals industry, in the medicinal chemical and botanical products segment.
The compliance status of Maxtreme Pharma is compliant as of 05 August 2026. The company is actively filing with the Registrar of Companies.